Synthesis of marimastat and a marimastat conjugate for affinity chromatography and surface plasmon resonance studies

Bioconjugate Chemistry

Volumn 15, Issue 3, 2004, Pages 594-600

  Jenssen, Kai ^a   Sewald, Katherina ^a   Sewald, Norbert ^a  

^a BIELEFELD UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMOLECULES; SURFACE PLASMON RESONANCE;

ASYMMETRIC SYNTHESIS; HYDROXAMATE; MATRIX; METALLOPROTEINASES; SENSOR CHIPS; SITE-SPECIFIC; SMALL-MOLECULE INHIBITORS; SOLID SURFACE; SURFACE PLASMON RESONANCE SENSOR; SURFACE-PLASMON RESONANCE;

AFFINITY CHROMATOGRAPHY;

HYDROXAMIC ACID DERIVATIVE; MARIMASTAT; METALLOPROTEINASE;

AFFINITY CHROMATOGRAPHY; ARTICLE; CONJUGATE; DRUG BINDING; DRUG SYNTHESIS; SOLID; SURFACE PLASMON RESONANCE; SURFACE PROPERTY; TECHNIQUE;

EID: 2442659417     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc034225l     Document Type: Article

References (20)

1. Turkova, J. (1978) Affinity Chromatography, pp 1-11, Elsevier Scientific Publishing Company, Amsterdam-Oxford-New York.
2. Myszka, D. G., and Rich, R. L. (2000) Implementing surface plasmon resonance biosensors in drug discovery. Pharm. Sci. Technol. Today 3, 310-317.
3. Hagenstein, M. C., Mussgnug, J. H., Lotte, K., Plessow, R., Brockhinke, A., Kruse, O., and Sewald, N. (2003) Affinitätsbasierte Markierung von Proteinfamilien mit reversiblen Inhibitoren - ein Konzept für die funktionelle Proteomik. Angew. Chem. 115, 5793-5796; Affinity-based tagging of protein families with reversible inhibitors: a concept for functional proteomics. Angew. Chem., Int. Ed. Engl. 42, 5635-5638.
4. Hagenstein, M. C., Mussgnug, J. H., Lotte, K., Plessow, R., Brockhinke, A., Kruse, O., and Sewald, N. (2003) Affinitätsbasierte Markierung von Proteinfamilien mit reversiblen Inhibitoren - ein Konzept für die funktionelle Proteomik. Angew. Chem. 115, 5793-5796; Affinity-based tagging of protein families with reversible inhibitors: a concept for functional proteomics. Angew. Chem., Int. Ed. Engl. 42, 5635-5638.
5. Yamamoto, M., Tsujishita, H., Hori, N., Ohishi, Y., Inoue, S., Ikeda, S., and Okada, Y. (1998) Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket. J. Med. Chem. 41, 1209-1217.
6. Levy, D. E., Lapierre, F., Liang, W., Lange, C. W., Li, X., Grobelny, D., Casabonne, M., Tyrrel, D., Holme, K., Nadzan, A., and Galardy, R. E. (1998) Matrix metalloproteinase inhibitors: a structure-activity study. J. Med. Chem. 41, 199-223.
7. Whittaker, M., Floyd, C. D., Brown, P., and Gearing, A. J. H. (1999) Design and therapeutic application of matrix metalloproteinase inhibitors. Chem. Rev. 99, 2735-2776.
8. Beckett, R. P., Davidson, A. H., Drummond, A. H., Huxley, P., and Whittaker, M. (1999) Recent advances in matrix metalloproteinase inhibitor research. Drug Discovery Today 1, 16-26.
9. Rasmussen, H. S., and McCann, P. P. (1997) Matrix metalloproteinase inhibition as a special novel strategy: a review with special focus on batimastat and marimastat. Pharmacol. Ther. 75, 69-75.
10. Pratt, L. M., Beckett, R. P., Corkill, D. J., Cossins, J., Courtney, P. F., Davies, J. D., Davidson, A. H., Drummond, A. H., Helfrich, K., Lewis, C. N., Mangan, M., Martin, F. M., Miller, K., Nayee, P., Ricketts, M. L., Thomas, W., Todd, R. S., and Whittaker, M., (1998) The synthesis of novel metalloproteinase inhibitors employing the Ireland-Claisen rearrangement. Bioorg. Med. Chem. Lett. 8, 1359-1364.
11. Barlaam, B., Koza, P., and Berriot, J. (1999) Solid-phase synthesis of hydroxamic acid based TNF-α convertase inhibitors. Tetrahedron 55, 7221-7232.
12. Mori, K., Iwasawa, H. (1980) Stereoselective synthesis of optically active forms of δ-multistrain, the attractant for european populations of the smaller elm bark beetle. Tetrahedron 36, 87-90.
13. Pirrung, M. C., Hang, H., Nunn, D. S., (1994) Kinetic mechanism and reaction pathway of thermus thermophilus isopropylmalate dehydrogenase. J. Org. Chem. 59, 2423-2429.
14. Weygand, F., and Burger, K., (1966) 2,2-Bis-trifluormethyl-1,3-dioxolanone-(4). Chem. Ber. 99, 2880-2884.
15. Burger, K., Windeisen, E., and Pires, R., (1995) New efficient strategy for the incorporation of (S)-isoserine into peptides. J. Org. Chem. 60, 7641-7645.
16. Halab, L., and Lubell, W. D., (1999) Use of steric interactions to control peptide turn geometry. Synthesis of type VI β-turn mimics with 5-tert-butylproline. J. Org. Chem. 64, 3312-3321.
17. Ye, T., and McKervey, M. A., (1992) Chiral N-protected α-amino-β-diketones. Tetrahedron 48, 8013-8014.
18. Barlos, K., Gatos, D., Kallitsis, I., Papaioannou, D., and Sotiriu, P., (1988) Anwendung von 4-Polystyryltriphenylmethylchlorid zur Synthese von Peptiden und Aminosäuren. Liebigs Ann. Chem., 1079-1081.
19. Barlos, K., Gatos, D., Kallitsis, J., Papaphotiu, G., Sotiriu, P., Wenging, Y., and Schäfer, W., (1989) Darstellung geschützter Peptid-Fragmente unter Einsatz substituierter Triphenylmethyl-Harze. Tetrahedron Lett. 30, 3943-3950.
20. Nash, I. A., Bycroft, B. W., and Chan, W. C., (1996) Dde - a selective primary amine protecting group: a facile solid-phase approach to polyamine conjugates. Tetrahedron Lett. 37, 2625-2628.